Event Report
-
Public Relations Committee
The 44th Public Relations Seminar
～The 44th Public Relations Seminar - Message Writing and Diction -
Secretariat
BioJapan2025 Luncheon Seminar "Meeting the Challenges of Access to Medicines: Co-creation between the Public and Private Sectors
-
Biopharmaceutical Committee
Report on BioJapan 2025
Opening Ceremony, Keynote Speech and Biopharmaceutical Seminar -
International Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
～The 11th Nikkei-FT Conference on Infectious Diseases held -
Biopharmaceutical Committee
The "Pharmaceutical Consortium of Japan Media Forum" (Part 2)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Committee
The "Pharmaceutical Manufacturers' Association of Japan (PMAJ) Media Forum" (Part 1)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
Public Relations Committee
The 43rd Public Relations Seminar" was held.
～The 44th Public Relations Seminar - Message Writing and Diction -
Secretariat
President Kinoshita of the Pharmaceutical Manufacturers Association of Japan (PAPJ) speaks at a panel organized by "Endpoints News" in the U.S.
-
Secretariat
Dr. Ishida, Executive Director of the Pharmaceutical Manufacturers Association of Japan (PAPJ), speaks at an online event for students
-
Public Relations Committee
The 36th Pharmaceutical Association of Japan (PAK) Policy Seminar held
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Diverse Values of Pharmaceuticals "What are the diverse values brought by new modalities - Case study of SMA (Spinal Muscular Atrophy) -
Industry Policy Committee
Report on the "Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
Symposium co-hosted by the Pharmaceutical Manufacturers Association of Japan (PMAJ) and RDD Japan Secretariat -
Industry Policy Committee
Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
-
Intellectual Property Committee
2025 Life Science Intellectual Property Forum" was held by the Japan Pharmaceutical Manufacturers Association (JPMA).
Intellectual Property Work at a Turning Point - What is Required of the Personnel Who Handle It -
Biopharmaceutical Committee
CMC Strategy Forum Japan 2024" was held.
-
Secretariat
The 23rd Pharmaceutical Association of Japan Forum" was held
-
Industry Policy Committee
The 4th Economic Security Seminar" held
Latest Trends of Cyber Threats and the Pharmaceutical Industry -
International Committee
Special session held at the "11th Nikkei-FT Conference on Infectious Diseases
Establishment of an Infectious Drug Discovery Ecosystem - Toward the Implementation Phase -
Public Relations Committee
The 42nd Public Relations Seminar" was held
～Public Relations Activities from the Perspective of Patients and Their Families -
Biopharmaceutical Committee
Report on "BioJapan 2024" and its participation
Opening Ceremony, Keynote Speech and Biopharmaceutical Committee Seminar -
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Initiatives for Priority Infectious Diseases (including AMR)
-Introduction of the Revised Government Action Plan for Pandemic Influenza and Future Responses -
Biopharmaceutical Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Life Course Immunization in the 100-year life era -
Public Relations Committee
The 41st Public Relations Seminar held
How to work in the age of AI -
Public Relations Committee
The 35th Pharmaceutical Association of Japan Policy Seminar held
Aiming for a Nation Driven by Innovation - Strengthening Japan's Drug Discovery Capability and Universal Health Coverage -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families -
Intellectual Property Committee
Held "2024 Life Science Intellectual Property Forum
Now is the time to strengthen Japan's drug discovery capabilities! ～Toward Building a Robust Drug Discovery Ecosystem for New Modalities -
Industry Policy Committee
Rare Disease Day 2024 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
-
ICH Project
The 5th ICH Forum: ICH Quality Guideline Update
-
Secretariat
The 22nd Pharmaceutical Association of Japan Forum
-
International Committee
Joint Conference on Global Health 2023" was held
Cosponsored symposium on "Drug Resistance (AMR) as a Global Health Challenge -
Public Relations Committee
The 40th Public Relations Seminar" held
-Social networking and web literacy seminar -
International Committee
Special Session held at the 10th Nikkei-FT Conference on Infectious Diseases
Toward the establishment of a drug discovery ecosystem in the field of infectious diseases - A review of the past year and future initiatives -
Biopharmaceutical Committee
Report on "BioJapan 2023" held and participation
Opening Ceremony, Keynote Speech and Biopharmaceutical Committee Seminar -
Industry Policy Committee
Held "Economic Security and Cyber Security" seminar
-
International Committee
Joint Symposium by the Pharmaceutical Manufacturers' Association of Japan (PMAJ) Aging Group and the Health Policy Institute of Japan (HGPI)
Health Challenges Associated with Aging, Dementia and Cancer - Early initiatives to extend healthy life expectancy -
Pharmaceutical Industry Policy Institute
Forum on "The Value of Pharmaceuticals and DTx to the Public" organized by the Institute for Policy Studies
-
Public Relations Committee
Held the 39th Public Relations Seminar
～What was discussed at the expert panel meeting? -
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Action Plan 2023-2027 to combat drug resistance (AMR) - Key points and future actions -
Industry Policy Committee
Economic Security Seminar "Economic Security and the Pharmaceutical Industry
-
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Health and Economy: "The World's Attention: The Future of Health Economics Research in Japan's Aging Society" (Japanese only) -
International Committee
Joint Symposium with the Joint Meeting of the Japanese Society of Infectious Diseases and the Japanese Society of Chemotherapy held
Bringing antimicrobials from Japan back to the world! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration -
Biopharmaceutical Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
What to do about vaccines? -What we can do now for the future -
Public Relations Committee
34th Pharmaceutical Association of Japan Policy Seminar held.
Toward Revival of Japan's Innovation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinstatement? -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
-Trends in science, technology and innovation from a bird's eye view of the life science field and their implications for the drug discovery field -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Business Models of the Pharmaceutical Industry and Pharmaceutical Industry Policies and Recommendations 2023 -
Intellectual Property Committee
The 2023 Life Science Intellectual Property Forum was held.
-Current Status, Prospects and Challenges of Digital Therapeutics (DTx) -
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" held
-
Patient Organization Collaboration Promotion Committee
The 40th Pharmaceutical Manufacturers Association of Japan (PMAJ) Patient Group Seminar held
Thinking Together and Taking the First Step: Patient and Public Involvement in Healthcare (PPI) -
Secretariat
The 21st Pharmaceutical Association of Japan Forum held
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
-Drug Resistance (AMR) Awareness Month -
Public Relations Committee
The 38th Public Relations Seminar held
-ESG Management, Disclosure, and the Relationship with Society -
Biopharmaceutical Committee
Report on "BioJapan 2022" and its participation.
About the Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Relations Committee
The Pharmaceutical Association of Japan (PAJ) Chairman speaks at a special session of "Nikkei Cross Health EXPO 2022".
Direction and Challenges of Pharmaceutical Companies' Transformation in the Era of Innovation Ecosystem -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Aiming for Appropriate Use of Drugs - To deliver reliable drug information to patients -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families -
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Relations Committee
The 37th Public Relations Seminar held
～News Commentary and News Program Production Today -
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
Public Relations Committee
34th Pharmaceutical Association of Japan Policy Seminar held.
Toward Revival of Japan's Innovation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinstatement? -
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Vaccination in the Era of With Corona ~Learning from Pandemics -
Secretariat
The 20th Pharmaceutical Association of Japan Forum held
-
Patient Organization Collaboration Promotion Committee
The 39th Pharmaceutical Association of Japan Patient Group Seminar held
Let's Think Together, Future Drug Development (Clinical Trials) - Let's Open the Door to the Future Together -
International Committee
Special program held at the 8th Nikkei-FT Conference on Infectious Diseases
Preparing for emerging and re-emerging infectious diseases, including drug-resistant bacteria - Unknown threats, a national response -
Public Relations Committee
Held the 36th Public Relations Seminar.
From Strategic PR to Narrative Company - New PR and the New Normal -
Biopharmaceutical Committee
Report on "BioJapan 2021" and its participation
About the Biopharmaceutical Committee Seminar -
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
The need for new antimicrobial agents against drug resistance (AMR) reaffirmed by the new coronavirus pandemic -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Reconsidering the Diverse Values of Pharmaceuticals - What Contributions to Society are Expected from Pharmaceuticals? -
Public Relations Committee
Held the 32nd Pharmaceutical Association of Japan Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Public Relations Committee
Held the 32nd Pharmaceutical Association of Japan Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Intellectual Property Committee
Held the "2021 Life Science Intellectual Property Forum
Theme is "How to handle IP rights in pandemic response measures including COVID-19" -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
What is a Vaccine? -Learning about vaccines once again in the Corona Disaster -With -
Patient Organization Collaboration Promotion Committee
The 38th Pharmaceutical Association of Japan Patient Group Seminar held
Online-based patient group activities - What we can do now -
ICH Project
GCP Renovation Seminar" held
-
Biopharmaceutical Committee
Report on the BioJapan 2020
About the Biopharmaceutical Committee Seminar -
International Committee
The 7th Nikkei-FT Conference on Infectious Diseases" held as a Pharmaceutical Association of Japan lunch session.
Recommendations to strengthen future infectious disease control through industry-academia-government collaboration -
Intellectual Property Committee
2020 Life Science Intellectual Property Forum" held.
How to protect new businesses that use digital data as a source of value -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Asuka Miyabashira, new president of the Pharmaceutical Manufacturers Association of Japan (PMAJ), delivers her policy statement -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
The Pharmaceutical Manufacturers Association of Japan (PALMA) publishes Industry Vision 2035 and PALMA Policy Proposal 2025 -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Expectations for the new administration -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Aiming for a country where innovation is dynamic -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Hiroaki Ueno, new chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), delivers his policy statement -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Recognition of the current situation and issues surrounding the pharmaceutical industry and the basic framework for solving them -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Yasuji Okada, new Chairman of the Board of Directors, delivers his policy statement -
Public Relations Committee
JPMA/PhRMA/EFPIA joint press conference held
Proposals for the Formulation of "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Relations Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Proposals for the Formulation of "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Necessity of Industrial Policy in the Pharmaceutical Industry" and "The Pharmaceutical Manufacturers Association of Japan Policy Proposal 2021 -
Public Relations Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Lessons learned from the spread of the new coronavirus and preparations for drug resistance (AMR) -
Public Relations Committee
Chairman's Press Conference" held
The Pharmaceutical Manufacturers Association of Japan (PMAJ) Activity Policy for FY2020, PMAJ Proposals for the Creation of Infectious Drugs and Vaccines, Proposals for the Framework Policy 2020, and Progress of the PMAJ Policy Recommendations 2019 -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Pharmaceutical Manufacturers Association of Japan: Progress and Future - Pursuing Innovation and Solving Social Issues
-
Public Relations Committee
Held a hands-on event "Pharmaceutical Cooperative Association of Japan Kusurium Laboratory
Three new exhibits are also on display in the permanent exhibition "Drugs Room - Cusrium". -
Public Relations Committee
The event to raise awareness of pharmaceutical and medical issues, "Living with Disease. Living with Hope. Photo Exhibition" was held.
To the future that creates, answers that have yet to be seen. -
Public Relations Committee
Special program by the Pharmaceutical Manufacturers Association of Japan "From Iwate" (TV-Iwate) Oraho's Health Protected by Drugs: Ten Years after the Earthquake and the Need for Countermeasures to Combat Infectious Diseases
*Not available for viewing in 2021 -
Public Relations Committee
Medical Information Program "Ijin Yakushin Yume no Meditemple 2021 Special" is now being broadcast by popular demand!
-
Public Relations Committee
Special program by the Pharmaceutical Manufacturers Association of Japan "Yamaguchi! Buchi Genki! ～KRY Yamaguchi Broadcasting Corporation "Yamaguchi!
-
APAC Project
Visit to 3 Southeast Asian countries for the 15th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations)
- Mission: Enhancing access to innovative medicines for the people in Asia - - The "Kusurium", a permanent exhibition
～Mission: Enhancing access to innovative medicines for the people in Asia - -
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Report on Side Events Held during the UN General Assembly
Global expansion of NCDs control through Japan-originated innovation and multi-stakeholder partnerships: Pathways to realization of UHC -
Code Compliance Promotion Committee
Held the "2025 Meeting of Code Administration Managers and Practitioners
-
Quality Committee
Holding of "The 52nd GMP Case Study Workshop in FY 2025
Strengthening Quality Assurance Implementation Capability and Site-Driven Problem Solving Approach -
Regulatory Affairs Committee
The 15th Annual Conference of the Regulatory Science Society of Japan to be held
Quality Assurance and Regulatory Science -
International Committee
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
Secretariat
Held the first "Co-creation Meeting" of the Pharmaceutical Manufacturers Association of Japan (PMAJ)!
Committee Chairs, Executives, and Secretariat Meet to Discuss the Realization of Industrial Vision 2035 -
International Committee
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industries from Japan and Korea gathered to discuss common issues -
International Committee
Strengthening Strategic Partnerships to Combat Infectious Diseases (Vector-Borne Diseases, Neglected Tropical Diseases, Emerging Infectious Diseases)" at the WHA78 side event in Geneva
Japan's Contributions and Strategic Partnerships in the Fight against Infectious Diseases -
Industry Policy Committee
Pharmaceutical Association of Japan members participate in the DIA 2025 Global Annual Meeting
Communicating to the world about efforts to tackle the drug lag and loss problem -
APAC Project
The 14th APAC (Asian Association of Pharmaceutical Manufacturers and Associations) Conference was held.
Mission: Rapidly bring innovative medicines to the people of Asia -
Regulatory Affairs Committee
Joint General Meeting of the Drug Evaluation Committee and Pharmaceutical Affairs Committee for FY 2025
-
International Committee
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
Product Information Summary Review Meeting
Held the "FY2024 Workshop for Persons Responsible for Product Information Outline Management and Practice Managers
-
Code Compliance Promotion Committee
Held the "FY2024 Meeting for Persons Responsible for Compliance Management and Practitioners".
-
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
International Committee
The 2nd Neglected Tropical Diseases Contest" was held.
-
Drug Evaluation Committee
FY2024 General Meeting of the Drug Evaluation Committee held.
Patient and Public Involvement" to be considered now - For whom our activities are for -
ICH Project
ICH Montreal Meeting" was held.
-
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
International Committee
The 12th Japan-Taiwan Pharmaceutical Exchange Conference held
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
Code Compliance Promotion Committee
The "2024 Meeting of Code Administration Managers and Practitioners" was held
-
Regulatory Affairs Committee
14th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to Open the Future of Medicine -
APAC Project
Held "2024 Asia-Pacific Economic Cooperation Conference Regulatory Harmonization Steering Committee (APEC RHSC)
-
International Committee
The 7th Japan-India Symposium on Regulation of Medical Products held in New Delhi
-
ICH Project
ICH Fukuoka Meeting held
-
International Committee
Japan Session" held at DIA China 2024 jointly by PMDA and the Pharmaceutical Manufacturers Association of Japan (PMAJ)
-
Drug Evaluation Committee
The Joint General Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee for 2024 was held.
-
APAC Project
The 13th Asian Pharmaceutical Association Conference (APAC) was held.
-Mission: To rapidly deliver innovative medicines to the people of Asia -
Industry Policy Committee
Briefing session on the revision of the cost-effectiveness evaluation system in 2024.
-
Code Compliance Promotion Committee
Held the "Meeting of Compliance Managers and Practitioners for 2023
-
International Committee
Held the "World NTD Day 2024: The First Neglected Tropical Diseases Student Contest and Online Event
-
International Committee
The 10th Japan-Thailand Joint Symposium" held
-
International Committee
The 4th Japan-Vietnam Joint Symposium" was held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2023" held
-
Drug Evaluation Committee
The "2023 Annual Meeting of the Committee for the Evaluation of Pharmaceutical Products" was held.
Breakthrough to Drug Loss - Aiming to realize safe, secure and wellbeing medicine and society -
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Prague Meeting" was held.
-
Drug Evaluation Committee
Workshop on "Next Generation Adverse Reaction Case Evaluation Workshops" was held
-
Product Information Summary Review Meeting
Briefing session on the revision of the "Guidelines for the Preparation of Product Information Summaries for Ethical Drugs" was held
-
International Committee
The 11th Japan-Taiwan Pharmaceutical Exchange Conference held
-
Code Compliance Promotion Committee
Held "Meeting of Code Administration Managers and Practitioners for 2023
-
Regulatory Affairs Committee
The 13th Annual Meeting of the Regulatory Science Society of Japan held
Progress and Harmony Required in Regulatory Science -
Quality Committee
Held the 50th GMP Case Study Workshop in 2023
-
APAC Project
Held the "2023 APEC Good Registration Management (GRM),Center of Excellence (CoE) Workshop
First local event after the COVID-19 pandemic -
International Committee
Held the "5th Japan-Korea Symposium on Medical Product Regulations
-
International Committee
Held "Opinion Exchange Meeting with Mr. Dao Hong Lang, Minister of Health, Vietnam
-
ICH Project
ICH Vancouver Meeting" held
-
Pharmaceutical Counseling and Response Review Committee
General Meeting of the Pharmaceutical Consultation and Response Study Group for FY2023 held.
-
Regulatory Affairs Committee
The "Joint General Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee in 2023" was held.
-
APAC Project
Held the 12th Asian Pharmaceutical Association Conference (APAC)
-Speedy delivery of innovative medicines to the people of Asia-. -
Code Compliance Promotion Committee
Held the FY2022 Meeting of Compliance Managers and Practitioners
-
International Committee
The 6th Japan-India Symposium on Regulation of Medical Products was held.
-
International Committee
The 9th Japan-Thailand Joint Symposium held
-
International Committee
Held the 3rd Japan-Vietnam Joint Symposium
-
APAC Project
The 1st APAC e-labeling Regulators' Workshop held
-
Drug Evaluation Committee
The "General Meeting of the Drug Evaluation Committee for FY2022" was held
Paving the way for the future of healthcare through Digital Transformation! ～From Disease to Pre-Disease and Well being -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
International Committee
Held a special session at the 9th Nikkei-FT Conference on Infectious Diseases
Toward the creation of a drug discovery ecosystem in the field of infectious diseases - Focusing on collaboration between industry, government, and academia -
ICH Project
ICH Incheon Meeting" was held.
-
Pharmaceutical Industry Policy Institute
The Economics of Invention", a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Culture Award.
-
International Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference held
-
Code Compliance Promotion Committee
The "2022 Meeting of Code Administration Managers and Practitioners" was held.
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan held
Current and Future Human Resource Development for Regulatory Science -
International Committee
The 2nd Japan-Malaysia Symposium was held
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Athens Meeting" held in a hybrid format for the first time
-
Drug Evaluation Committee
The "Joint Meeting of the Drug Evaluation Committee and the Regulatory Affairs Committee" was held.
-
APAC Project
The 11th APAC (Asian Pharmaceutical Association Conference) was held.
-Mission: Rapidly Deliver Innovative Medicines to the People of Asia
Theme: "Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade of APAC -
Product Information Summary Review Meeting
Held the "FY2021 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice".
-
Industry Policy Committee
Held a briefing session on the Cost-Effectiveness Evaluation System
-
ICH Project
Report on the "eCTD v4.0 (ICH M8) Notification Revision and Start of Operation Briefing Session
-
Code Compliance Promotion Committee
Held the "FY2021 Meeting of Compliance Managers and Practitioners
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
The 8th Japan-Thailand Joint Symposium" was held
-
International Committee
The 5th Japan-India Symposium on Medical Products Regulations" held
Proactive communication for the development of Japan-India cooperation scheme in the field of pharmaceuticals -
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2021" held
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Vancouver Meeting" held via web conference
-
Drug Evaluation Committee
The 139th Annual Meeting of the Committee on Drug Evaluation held
Reflecting on the New Coronavirus - Sharing Best Practices and Resolving Domestic Issues -
Pharmaceutical Industry Policy Institute
Workshop on the Value of Drugs: Considering the Value of Drugs and Their Evaluation from the Perspective of the Public and Patients" was held by the Policy Research Institute
-
International Committee
The 9th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
-
International Committee
Held "Regular Meeting with the French Association of the Pharmaceutical Industry (LEEM)
-
Industry Policy Committee
Held "Pharmaceutical Industry Vision 2021 Briefing Session
-
Code Compliance Promotion Committee
Held "Meeting of Code Administration Managers and Practitioners for 2021
-
Regulatory Affairs Committee
The 11th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to Accelerate Social Implementation -
Industry Policy Committee
Held "Briefing on the Revised Guideline for the Special Tax Credit System for Experiment and Research Expenses
-
Quality Committee
The 48th GMP Case Study Workshop in 2021" held
-
ICH Project, International Committee
Held the "Japan-China ICH Joint Symposium
-
ICH Project
ICH Incheon Conference" held via web conference
-
International Committee
COVID-19 Session" jointly held by PMDA and the Pharmaceutical Manufacturers Association of Japan (PMAJ) at DIA China 2021
-
International Committee
The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
-
Regulatory Affairs Committee
Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee for 2021" was held.
-
APAC Project
The 10th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference held
-Mission: Rapidly bring innovative medicines to the people of Asia-.
The theme is "Overcoming COVID-19 and Towards a Decade of New Innovation Challenges in Asia -
Product Information Summary Review Meeting
Held "FY2020 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice
-
Code Compliance Promotion Committee
Held the FY2020 Compliance Managers and Practitioners Meeting.
-
International Committee
Discussions with the International Atomic Energy Agency (IAEA) and the Permanent Mission of Japan to the International Organizations in Vienna on various issues in the health sector.
-
International Committee
The 7th Japan-Thailand Joint Symposium" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2020" was held.
-
International Committee
The 2nd Japan-Vietnam Joint Symposium was held.
-
Drug Evaluation Committee
The Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee 2020 was held.
-
International Committee
The 8th Taiwan-Japan Pharmaceutical Exchange Conference held.
-
Code Compliance Promotion Committee
FY2020 Meeting of Code Administration Managers and Practitioners" held
-
Regulatory Affairs Committee
The 10th Annual Meeting of the Regulatory Science Society of Japan held
-
Quality Committee
Held the 47th GMP Case Study Workshop in FY2020
-
ICH Project
ICH M8 eCTD v4.0 Revision Notice Briefing Session
Briefing Session on eCTD v4.0 Implementation in Japan -
ICH Project
ICH Vancouver Conference" held in web conference format
-
Quality Committee
The 22nd Pharmaceutical Quality Forum Symposium" was held
Current Status of ICH-Q Series -
Regulatory Affairs Committee
The 8th Symposium of the Pharmaceutical Affairs Committee held
Considering what can be done to make the face-to-face advice and review more efficient -
International Committee
The 4th Symposium on Japan-India Medical Products Regulations" was held
Mature discussion on drug regulation between Japan and India (Japan-India) and further development into an international cooperation scheme
-
APAC Project
Visit to 3 Southeast Asian countries for the 15th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations)
- Mission: Enhancing access to innovative medicines for the people in Asia - - The "Kusurium", a permanent exhibition
～Mission: Enhancing access to innovative medicines for the people in Asia - -
Public Relations Committee
The 44th Public Relations Seminar
～The 44th Public Relations Seminar - Message Writing and Diction -
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
Secretariat
BioJapan2025 Luncheon Seminar "Meeting the Challenges of Access to Medicines: Co-creation between the Public and Private Sectors
-
Biopharmaceutical Committee
Report on BioJapan 2025
Opening Ceremony, Keynote Speech and Biopharmaceutical Seminar -
International Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
～The 11th Nikkei-FT Conference on Infectious Diseases held -
International Committee
Report on Side Events Held during the UN General Assembly
Global expansion of NCDs control through Japan-originated innovation and multi-stakeholder partnerships: Pathways to realization of UHC -
Code Compliance Promotion Committee
Held the "2025 Meeting of Code Administration Managers and Practitioners
-
Quality Committee
Holding of "The 52nd GMP Case Study Workshop in FY 2025
Strengthening Quality Assurance Implementation Capability and Site-Driven Problem Solving Approach -
Regulatory Affairs Committee
The 15th Annual Conference of the Regulatory Science Society of Japan to be held
Quality Assurance and Regulatory Science -
Biopharmaceutical Committee
The "Pharmaceutical Consortium of Japan Media Forum" (Part 2)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Committee
The "Pharmaceutical Manufacturers' Association of Japan (PMAJ) Media Forum" (Part 1)
Two Major Issues in Countermeasures against Infectious Diseases: Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization -
International Committee
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
Secretariat
Held the first "Co-creation Meeting" of the Pharmaceutical Manufacturers Association of Japan (PMAJ)!
Committee Chairs, Executives, and Secretariat Meet to Discuss the Realization of Industrial Vision 2035 -
International Committee
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industries from Japan and Korea gathered to discuss common issues -
International Committee
Strengthening Strategic Partnerships to Combat Infectious Diseases (Vector-Borne Diseases, Neglected Tropical Diseases, Emerging Infectious Diseases)" at the WHA78 side event in Geneva
Japan's Contributions and Strategic Partnerships in the Fight against Infectious Diseases -
Industry Policy Committee
Pharmaceutical Association of Japan members participate in the DIA 2025 Global Annual Meeting
Communicating to the world about efforts to tackle the drug lag and loss problem -
Public Relations Committee
The 43rd Public Relations Seminar" was held.
～The 44th Public Relations Seminar - Message Writing and Diction -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Asuka Miyabashira, new president of the Pharmaceutical Manufacturers Association of Japan (PMAJ), delivers her policy statement -
Secretariat
President Kinoshita of the Pharmaceutical Manufacturers Association of Japan (PAPJ) speaks at a panel organized by "Endpoints News" in the U.S.
-
Secretariat
Dr. Ishida, Executive Director of the Pharmaceutical Manufacturers Association of Japan (PAPJ), speaks at an online event for students
-
APAC Project
The 14th APAC (Asian Association of Pharmaceutical Manufacturers and Associations) Conference was held.
Mission: Rapidly bring innovative medicines to the people of Asia -
Regulatory Affairs Committee
Joint General Meeting of the Drug Evaluation Committee and Pharmaceutical Affairs Committee for FY 2025
-
International Committee
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
Product Information Summary Review Meeting
Held the "FY2024 Workshop for Persons Responsible for Product Information Outline Management and Practice Managers
-
Public Relations Committee
Held a hands-on event "Pharmaceutical Cooperative Association of Japan Kusurium Laboratory
Three new exhibits are also on display in the permanent exhibition "Drugs Room - Cusrium". -
Code Compliance Promotion Committee
Held the "FY2024 Meeting for Persons Responsible for Compliance Management and Practitioners".
-
Public Relations Committee
The 36th Pharmaceutical Association of Japan (PAK) Policy Seminar held
Aiming to Improve Japan's Drug Discovery Capability: What Value Innovative New Drugs Bring to Society -
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Diverse Values of Pharmaceuticals "What are the diverse values brought by new modalities - Case study of SMA (Spinal Muscular Atrophy) -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
The Pharmaceutical Manufacturers Association of Japan (PALMA) publishes Industry Vision 2035 and PALMA Policy Proposal 2025 -
Industry Policy Committee
Report on the "Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
Symposium co-hosted by the Pharmaceutical Manufacturers Association of Japan (PMAJ) and RDD Japan Secretariat -
Industry Policy Committee
Rare Disease Day 2025 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
-
Intellectual Property Committee
2025 Life Science Intellectual Property Forum" was held by the Japan Pharmaceutical Manufacturers Association (JPMA).
Intellectual Property Work at a Turning Point - What is Required of the Personnel Who Handle It -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
International Committee
The 2nd Neglected Tropical Diseases Contest" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2024" was held.
-
Secretariat
The 23rd Pharmaceutical Association of Japan Forum" was held
-
Industry Policy Committee
The 4th Economic Security Seminar" held
Latest Trends of Cyber Threats and the Pharmaceutical Industry -
Drug Evaluation Committee
FY2024 General Meeting of the Drug Evaluation Committee held.
Patient and Public Involvement" to be considered now - For whom our activities are for -
ICH Project
ICH Montreal Meeting" was held.
-
International Committee
Special session held at the "11th Nikkei-FT Conference on Infectious Diseases
Establishment of an Infectious Drug Discovery Ecosystem - Toward the Implementation Phase -
Public Relations Committee
The 42nd Public Relations Seminar" was held
～Public Relations Activities from the Perspective of Patients and Their Families -
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
Biopharmaceutical Committee
Report on "BioJapan 2024" and its participation
Opening Ceremony, Keynote Speech and Biopharmaceutical Committee Seminar -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Expectations for the new administration -
International Committee
The 12th Japan-Taiwan Pharmaceutical Exchange Conference held
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Initiatives for Priority Infectious Diseases (including AMR)
-Introduction of the Revised Government Action Plan for Pandemic Influenza and Future Responses -
Code Compliance Promotion Committee
The "2024 Meeting of Code Administration Managers and Practitioners" was held
-
Regulatory Affairs Committee
14th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to Open the Future of Medicine -
Biopharmaceutical Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Life Course Immunization in the 100-year life era -
APAC Project
Held "2024 Asia-Pacific Economic Cooperation Conference Regulatory Harmonization Steering Committee (APEC RHSC)
-
International Committee
The 7th Japan-India Symposium on Regulation of Medical Products held in New Delhi
-
ICH Project
ICH Fukuoka Meeting held
-
Public Relations Committee
The 41st Public Relations Seminar held
How to work in the age of AI -
International Committee
Japan Session" held at DIA China 2024 jointly by PMDA and the Pharmaceutical Manufacturers Association of Japan (PMAJ)
-
Drug Evaluation Committee
The Joint General Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee for 2024 was held.
-
APAC Project
The 13th Asian Pharmaceutical Association Conference (APAC) was held.
-Mission: To rapidly deliver innovative medicines to the people of Asia -
Industry Policy Committee
Briefing session on the revision of the cost-effectiveness evaluation system in 2024.
-
Public Relations Committee
The event to raise awareness of pharmaceutical and medical issues, "Living with Disease. Living with Hope. Photo Exhibition" was held.
To the future that creates, answers that have yet to be seen. -
Code Compliance Promotion Committee
Held the "Meeting of Compliance Managers and Practitioners for 2023
-
Public Relations Committee
The 35th Pharmaceutical Association of Japan Policy Seminar held
Aiming for a Nation Driven by Innovation - Strengthening Japan's Drug Discovery Capability and Universal Health Coverage -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Aiming for a country where innovation is dynamic -
Intellectual Property Committee
Held "2024 Life Science Intellectual Property Forum
Now is the time to strengthen Japan's drug discovery capabilities! ～Toward Building a Robust Drug Discovery Ecosystem for New Modalities -
Industry Policy Committee
Rare Disease Day 2024 Symposium" held by the Pharmaceutical Manufacturers Association of Japan
-
International Committee
Held the "World NTD Day 2024: The First Neglected Tropical Diseases Student Contest and Online Event
-
International Committee
The 10th Japan-Thailand Joint Symposium" held
-
ICH Project
The 5th ICH Forum: ICH Quality Guideline Update
-
International Committee
The 4th Japan-Vietnam Joint Symposium" was held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2023" held
-
Secretariat
The 22nd Pharmaceutical Association of Japan Forum
-
Drug Evaluation Committee
The "2023 Annual Meeting of the Committee for the Evaluation of Pharmaceutical Products" was held.
Breakthrough to Drug Loss - Aiming to realize safe, secure and wellbeing medicine and society -
International Committee
Joint Conference on Global Health 2023" was held
Cosponsored symposium on "Drug Resistance (AMR) as a Global Health Challenge -
Public Relations Committee
The 40th Public Relations Seminar" held
-Social networking and web literacy seminar -
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Prague Meeting" was held.
-
Drug Evaluation Committee
Workshop on "Next Generation Adverse Reaction Case Evaluation Workshops" was held
-
International Committee
Special Session held at the 10th Nikkei-FT Conference on Infectious Diseases
Toward the establishment of a drug discovery ecosystem in the field of infectious diseases - A review of the past year and future initiatives -
Product Information Summary Review Meeting
Briefing session on the revision of the "Guidelines for the Preparation of Product Information Summaries for Ethical Drugs" was held
-
Biopharmaceutical Committee
Report on "BioJapan 2023" held and participation
Opening Ceremony, Keynote Speech and Biopharmaceutical Committee Seminar -
International Committee
The 11th Japan-Taiwan Pharmaceutical Exchange Conference held
-
Industry Policy Committee
Held "Economic Security and Cyber Security" seminar
-
Code Compliance Promotion Committee
Held "Meeting of Code Administration Managers and Practitioners for 2023
-
International Committee
Joint Symposium by the Pharmaceutical Manufacturers' Association of Japan (PMAJ) Aging Group and the Health Policy Institute of Japan (HGPI)
Health Challenges Associated with Aging, Dementia and Cancer - Early initiatives to extend healthy life expectancy -
Regulatory Affairs Committee
The 13th Annual Meeting of the Regulatory Science Society of Japan held
Progress and Harmony Required in Regulatory Science -
Quality Committee
Held the 50th GMP Case Study Workshop in 2023
-
APAC Project
Held the "2023 APEC Good Registration Management (GRM),Center of Excellence (CoE) Workshop
First local event after the COVID-19 pandemic -
International Committee
Held the "5th Japan-Korea Symposium on Medical Product Regulations
-
Pharmaceutical Industry Policy Institute
Forum on "The Value of Pharmaceuticals and DTx to the Public" organized by the Institute for Policy Studies
-
Public Relations Committee
Held the 39th Public Relations Seminar
～What was discussed at the expert panel meeting? -
International Committee
Held "Opinion Exchange Meeting with Mr. Dao Hong Lang, Minister of Health, Vietnam
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Action Plan 2023-2027 to combat drug resistance (AMR) - Key points and future actions -
Industry Policy Committee
Economic Security Seminar "Economic Security and the Pharmaceutical Industry
-
ICH Project
ICH Vancouver Meeting" held
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Hiroaki Ueno, new chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), delivers his policy statement -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Health and Economy: "The World's Attention: The Future of Health Economics Research in Japan's Aging Society" (Japanese only) -
Pharmaceutical Counseling and Response Review Committee
General Meeting of the Pharmaceutical Consultation and Response Study Group for FY2023 held.
-
International Committee
Joint Symposium with the Joint Meeting of the Japanese Society of Infectious Diseases and the Japanese Society of Chemotherapy held
Bringing antimicrobials from Japan back to the world! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration -
Regulatory Affairs Committee
The "Joint General Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee in 2023" was held.
-
APAC Project
Held the 12th Asian Pharmaceutical Association Conference (APAC)
-Speedy delivery of innovative medicines to the people of Asia-. -
Biopharmaceutical Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
What to do about vaccines? -What we can do now for the future -
Public Relations Committee
34th Pharmaceutical Association of Japan Policy Seminar held.
Toward Revival of Japan's Innovation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinstatement? -
Code Compliance Promotion Committee
Held the FY2022 Meeting of Compliance Managers and Practitioners
-
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
-Trends in science, technology and innovation from a bird's eye view of the life science field and their implications for the drug discovery field -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Business Models of the Pharmaceutical Industry and Pharmaceutical Industry Policies and Recommendations 2023 -
Intellectual Property Committee
The 2023 Life Science Intellectual Property Forum was held.
-Current Status, Prospects and Challenges of Digital Therapeutics (DTx) -
International Committee
The 6th Japan-India Symposium on Regulation of Medical Products was held.
-
International Committee
The 9th Japan-Thailand Joint Symposium held
-
ICH Project
The 4th ICH Forum: ICH Efficacy Guideline Update
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2022" held
-
Patient Organization Collaboration Promotion Committee
The 40th Pharmaceutical Manufacturers Association of Japan (PMAJ) Patient Group Seminar held
Thinking Together and Taking the First Step: Patient and Public Involvement in Healthcare (PPI) -
International Committee
Held the 3rd Japan-Vietnam Joint Symposium
-
APAC Project
The 1st APAC e-labeling Regulators' Workshop held
-
Drug Evaluation Committee
The "General Meeting of the Drug Evaluation Committee for FY2022" was held
Paving the way for the future of healthcare through Digital Transformation! ～From Disease to Pre-Disease and Well being -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
Secretariat
The 21st Pharmaceutical Association of Japan Forum held
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
International Committee
Held a special session at the 9th Nikkei-FT Conference on Infectious Diseases
Toward the creation of a drug discovery ecosystem in the field of infectious diseases - Focusing on collaboration between industry, government, and academia -
ICH Project
ICH Incheon Meeting" was held.
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
-Drug Resistance (AMR) Awareness Month -
Pharmaceutical Industry Policy Institute
The Economics of Invention", a book written by Director Nagaoka of the Policy Research Institute, won the 65th Nikkei Economic Book Culture Award.
-
International Committee
The 10th Japan-Taiwan Pharmaceutical Exchange Conference held
-
Public Relations Committee
The 38th Public Relations Seminar held
-ESG Management, Disclosure, and the Relationship with Society -
Biopharmaceutical Committee
Report on "BioJapan 2022" and its participation.
About the Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar -
Public Relations Committee
The Pharmaceutical Association of Japan (PAJ) Chairman speaks at a special session of "Nikkei Cross Health EXPO 2022".
Direction and Challenges of Pharmaceutical Companies' Transformation in the Era of Innovation Ecosystem -
Code Compliance Promotion Committee
The "2022 Meeting of Code Administration Managers and Practitioners" was held.
-
Regulatory Affairs Committee
The 12th Annual Meeting of the Regulatory Science Society of Japan held
Current and Future Human Resource Development for Regulatory Science -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Recognition of the current situation and issues surrounding the pharmaceutical industry and the basic framework for solving them -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Aiming for Appropriate Use of Drugs - To deliver reliable drug information to patients -
International Committee
The 2nd Japan-Malaysia Symposium was held
-
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Considering the Diverse Values of Pharmaceuticals - For the Rich Daily Lives Desired by Patients and Their Families -
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
ICH Project
ICH Athens Meeting" held in a hybrid format for the first time
-
Drug Evaluation Committee
The "Joint Meeting of the Drug Evaluation Committee and the Regulatory Affairs Committee" was held.
-
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
～The current state of drug resistance (AMR) and the need for new antimicrobial agents to address this challenge -
Public Relations Committee
The 37th Public Relations Seminar held
～News Commentary and News Program Production Today -
APAC Project
The 11th APAC (Asian Pharmaceutical Association Conference) was held.
-Mission: Rapidly Deliver Innovative Medicines to the People of Asia
Theme: "Building a Platform to Deliver Valuable Innovations to the People of Asia for the Next Decade of APAC -
Product Information Summary Review Meeting
Held the "FY2021 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice".
-
Industry Policy Committee
Held a briefing session on the Cost-Effectiveness Evaluation System
-
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
Public Relations Committee
The 33rd Pharmaceutical Association of Japan Policy Seminar held
Toward the Creation of Innovative New Drugs from Japan - Creating a Healthcare Ecosystem that Generates Continuous Innovation -
Public Relations Committee
34th Pharmaceutical Association of Japan Policy Seminar held.
Toward Revival of Japan's Innovation Potential: Will the Healthcare Ecosystem Lead to Japan's Reinstatement? -
ICH Project
Report on the "eCTD v4.0 (ICH M8) Notification Revision and Start of Operation Briefing Session
-
Code Compliance Promotion Committee
Held the "FY2021 Meeting of Compliance Managers and Practitioners
-
Intellectual Property Committee
The "2022 Life Science Intellectual Property Forum" was held.
-COVID-19 Pandemic: Challenges and Prospects for Innovation Ecosystems -COVID-19 Pandemic: Challenges and Prospects for Solutions -
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
The 8th Japan-Thailand Joint Symposium" was held
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Toward Full-Scale Discussion of Pharmaceutical Industry Policies: Current Situation and Recognition of Issues -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Vaccination in the Era of With Corona ~Learning from Pandemics -
International Committee
The 5th Japan-India Symposium on Medical Products Regulations" held
Proactive communication for the development of Japan-India cooperation scheme in the field of pharmaceuticals -
International Committee
Held "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2021" held
-
International Committee
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
Secretariat
The 20th Pharmaceutical Association of Japan Forum held
-
Patient Organization Collaboration Promotion Committee
The 39th Pharmaceutical Association of Japan Patient Group Seminar held
Let's Think Together, Future Drug Development (Clinical Trials) - Let's Open the Door to the Future Together -
ICH Project
ICH Vancouver Meeting" held via web conference
-
Drug Evaluation Committee
The 139th Annual Meeting of the Committee on Drug Evaluation held
Reflecting on the New Coronavirus - Sharing Best Practices and Resolving Domestic Issues -
International Committee
Special program held at the 8th Nikkei-FT Conference on Infectious Diseases
Preparing for emerging and re-emerging infectious diseases, including drug-resistant bacteria - Unknown threats, a national response -
Pharmaceutical Industry Policy Institute
Workshop on the Value of Drugs: Considering the Value of Drugs and Their Evaluation from the Perspective of the Public and Patients" was held by the Policy Research Institute
-
Public Relations Committee
Held the 36th Public Relations Seminar.
From Strategic PR to Narrative Company - New PR and the New Normal -
International Committee
The 9th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
-
International Committee
Held "Regular Meeting with the French Association of the Pharmaceutical Industry (LEEM)
-
Biopharmaceutical Committee
Report on "BioJapan 2021" and its participation
About the Biopharmaceutical Committee Seminar -
Industry Policy Committee
Held "Pharmaceutical Industry Vision 2021 Briefing Session
-
Code Compliance Promotion Committee
Held "Meeting of Code Administration Managers and Practitioners for 2021
-
Regulatory Affairs Committee
The 11th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to Accelerate Social Implementation -
Industry Policy Committee
Held "Briefing on the Revised Guideline for the Special Tax Credit System for Experiment and Research Expenses
-
Quality Committee
The 48th GMP Case Study Workshop in 2021" held
-
ICH Project, International Committee
Held the "Japan-China ICH Joint Symposium
-
ICH Project
ICH Incheon Conference" held via web conference
-
International Committee
COVID-19 Session" jointly held by PMDA and the Pharmaceutical Manufacturers Association of Japan (PMAJ) at DIA China 2021
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Yasuji Okada, new Chairman of the Board of Directors, delivers his policy statement -
International Committee
The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
-
Public Relations Committee
JPMA/PhRMA/EFPIA joint press conference held
Proposals for the Formulation of "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Relations Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Proposals for the Formulation of "Framework Policy" and "Vision for the Pharmaceutical Industry -
International Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
The need for new antimicrobial agents against drug resistance (AMR) reaffirmed by the new coronavirus pandemic -
Regulatory Affairs Committee
Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee for 2021" was held.
-
APAC Project
The 10th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference held
-Mission: Rapidly bring innovative medicines to the people of Asia-.
The theme is "Overcoming COVID-19 and Towards a Decade of New Innovation Challenges in Asia -
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Necessity of Industrial Policy in the Pharmaceutical Industry" and "The Pharmaceutical Manufacturers Association of Japan Policy Proposal 2021 -
Industry Policy Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Reconsidering the Diverse Values of Pharmaceuticals - What Contributions to Society are Expected from Pharmaceuticals? -
Product Information Summary Review Meeting
Held "FY2020 Workshop for Persons Responsible for Product Information Outline Management and Persons Responsible for Practice
-
Code Compliance Promotion Committee
Held the FY2020 Compliance Managers and Practitioners Meeting.
-
Public Relations Committee
Held the 32nd Pharmaceutical Association of Japan Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Public Relations Committee
Held the 32nd Pharmaceutical Association of Japan Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Intellectual Property Committee
Held the "2021 Life Science Intellectual Property Forum
Theme is "How to handle IP rights in pandemic response measures including COVID-19" -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
What is a Vaccine? -Learning about vaccines once again in the Corona Disaster -With -
Public Relations Committee
Special program by the Pharmaceutical Manufacturers Association of Japan "From Iwate" (TV-Iwate) Oraho's Health Protected by Drugs: Ten Years after the Earthquake and the Need for Countermeasures to Combat Infectious Diseases
*Not available for viewing in 2021 -
International Committee
Discussions with the International Atomic Energy Agency (IAEA) and the Permanent Mission of Japan to the International Organizations in Vienna on various issues in the health sector.
-
International Committee
The 7th Japan-Thailand Joint Symposium" was held.
-
Public Relations Committee
Medical Information Program "Ijin Yakushin Yume no Meditemple 2021 Special" is now being broadcast by popular demand!
-
Patient Organization Collaboration Promotion Committee
The 38th Pharmaceutical Association of Japan Patient Group Seminar held
Online-based patient group activities - What we can do now -
ICH Project
GCP Renovation Seminar" held
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2020" was held.
-
International Committee
The 2nd Japan-Vietnam Joint Symposium was held.
-
Drug Evaluation Committee
The Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee 2020 was held.
-
International Committee
The 8th Taiwan-Japan Pharmaceutical Exchange Conference held.
-
Biopharmaceutical Committee
Report on the BioJapan 2020
About the Biopharmaceutical Committee Seminar -
Code Compliance Promotion Committee
FY2020 Meeting of Code Administration Managers and Practitioners" held
-
Regulatory Affairs Committee
The 10th Annual Meeting of the Regulatory Science Society of Japan held
-
Quality Committee
Held the 47th GMP Case Study Workshop in FY2020
-
Public Relations Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Lessons learned from the spread of the new coronavirus and preparations for drug resistance (AMR) -
Public Relations Committee
Chairman's Press Conference" held
The Pharmaceutical Manufacturers Association of Japan (PMAJ) Activity Policy for FY2020, PMAJ Proposals for the Creation of Infectious Drugs and Vaccines, Proposals for the Framework Policy 2020, and Progress of the PMAJ Policy Recommendations 2019 -
International Committee
The 7th Nikkei-FT Conference on Infectious Diseases" held as a Pharmaceutical Association of Japan lunch session.
Recommendations to strengthen future infectious disease control through industry-academia-government collaboration -
ICH Project
ICH M8 eCTD v4.0 Revision Notice Briefing Session
Briefing Session on eCTD v4.0 Implementation in Japan -
ICH Project
ICH Vancouver Conference" held in web conference format
-
Quality Committee
The 22nd Pharmaceutical Quality Forum Symposium" was held
Current Status of ICH-Q Series -
Regulatory Affairs Committee
The 8th Symposium of the Pharmaceutical Affairs Committee held
Considering what can be done to make the face-to-face advice and review more efficient -
Intellectual Property Committee
2020 Life Science Intellectual Property Forum" held.
How to protect new businesses that use digital data as a source of value -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
Pharmaceutical Counseling and Response Review Committee
The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
Considering how information should be provided to patients - Focusing on the next generation -
International Committee
The 4th Symposium on Japan-India Medical Products Regulations" was held
Mature discussion on drug regulation between Japan and India (Japan-India) and further development into an international cooperation scheme -
Public Relations Committee
Held the Pharmaceutical Manufacturers Association of Japan (PMAJ) Media Forum.
Trends in the revision of the Personal Information Protection Law and the legislative policy for medical information -
Public Relations Committee
Special program by the Pharmaceutical Manufacturers Association of Japan "Yamaguchi! Buchi Genki! ～KRY Yamaguchi Broadcasting Corporation "Yamaguchi!
-
Public Relations Committee
Press Conference of the President of the Pharmaceutical Manufacturers Association of Japan held.
Pharmaceutical Manufacturers Association of Japan: Progress and Future - Pursuing Innovation and Solving Social Issues